Copernicus Receives Milestone Payment From CFFT To Further Development Of Its Non-Viral Gene Therapy For Cystic Fibrosis
Copernicus Therapeutics, Inc. announced that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit affiliate of the Cystic Fibrosis Foundation. This milestone payment is part of a research, development, and commercialization agreement between CFFT and Copernicus to develop gene therapy to treat cystic fibrosis. [click link for full article]
More: continued here